{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T09:45:15Z","timestamp":1784022315671,"version":"3.55.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2010,1,20]],"date-time":"2010-01-20T00:00:00Z","timestamp":1263945600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1038\/ejhg.2009.238","type":"journal-article","created":{"date-parts":[[2010,1,20]],"date-time":"2010-01-20T11:25:05Z","timestamp":1263986705000},"page":"707-712","source":"Crossref","is-referenced-by-count":31,"title":["Genetic variants in the BDNF gene and therapeutic response to risperidone in schizophrenia patients: a pharmacogenetic study"],"prefix":"10.1038","volume":"18","author":[{"given":"Mingqing","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghe","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoyin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiguang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"St Clair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,1,20]]},"reference":[{"key":"BFejhg2009238_CR1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1056\/NEJMoa002028","volume":"346","author":"JG Csernansky","year":"2002","unstructured":"Csernansky JG, Mahmoud R, Brenner R : Risperidone-USA-79 Study Group. A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia. N Engl J Med 2002; 346: 16\u201322.","journal-title":"N Engl J Med"},{"key":"BFejhg2009238_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(08)61764-X","volume":"373","author":"S Leucht","year":"2009","unstructured":"Leucht S, Corves C, Arbter D, Engel RR, Li C, Davis JM : Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet 2009; 373: 31\u201341.","journal-title":"Lancet"},{"key":"BFejhg2009238_CR3","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/01.jcp.0000203196.65710.2b","volume":"26","author":"HY Lane","year":"2006","unstructured":"Lane HY, Liu YC, Huang CL et al: Risperidone-related weight gain: genetic and nongenetic predictors. J Clin Psychopharmacol 2006; 26: 128\u2013134.","journal-title":"J Clin Psychopharmacol"},{"issue":"4 Suppl 1","key":"BFejhg2009238_CR4","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1016\/j.amjmed.2007.02.005","volume":"120","author":"TS Stroup","year":"2007","unstructured":"Stroup TS : Heterogeneity of treatment effects in schizophrenia. Am J Med 2007; 120 (4 Suppl 1): S26\u2013S31.","journal-title":"Am J Med"},{"key":"BFejhg2009238_CR5","doi-asserted-by":"publisher","first-page":"987","DOI":"10.2217\/14622416.7.7.987","volume":"7","author":"Q Xing","year":"2006","unstructured":"Xing Q, Gao R, Li H et al: Polymorphisms of the ABCB1 gene are associated with the therapeutic response to risperidone in Chinese schizophrenia patients. Pharmacogenomics 2006; 7: 987\u2013993.","journal-title":"Pharmacogenomics"},{"key":"BFejhg2009238_CR6","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1017\/S146114570600719X","volume":"10","author":"Q Xing","year":"2007","unstructured":"Xing Q, Qian X, Li H et al: The relationship between the therapeutic response to risperidone and the dopamine D2 receptor polymorphism in Chinese schizophrenia patients. Int J Neuropsychopharmacol 2007; 10: 631\u2013637.","journal-title":"Int J Neuropsychopharmacol"},{"key":"BFejhg2009238_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neulet.2006.09.014","volume":"414","author":"L Wang","year":"2007","unstructured":"Wang L, Yu L, He G et al: Response of risperidone treatment may be associated with polymorphisms of HTT gene in Chinese schizophrenia patients. Neurosci Lett 2007; 414: 1\u20134.","journal-title":"Neurosci Lett"},{"key":"BFejhg2009238_CR8","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.2217\/14622416.8.10.1337","volume":"8","author":"A Zhang","year":"2007","unstructured":"Zhang A, Xing Q, Wang L et al: Dopamine transporter polymorphisms and risperidone response in Chinese schizophrenia patients: an association study. Pharmacogenomics 2007; 8: 1337\u20131345.","journal-title":"Pharmacogenomics"},{"key":"BFejhg2009238_CR9","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/sj.npp.1301418","volume":"33","author":"J Xuan","year":"2008","unstructured":"Xuan J, Zhao X, He G et al: Effects of the dopamine D3 receptor (DRD3) gene polymorphisms on risperidone response: a pharmacogenetic study. Neuropsychopharmacology 2008; 33: 305\u2013311.","journal-title":"Neuropsychopharmacology"},{"key":"BFejhg2009238_CR10","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1097\/FPC.0b013e32830500e2","volume":"18","author":"B Gu","year":"2008","unstructured":"Gu B, Wang L, Zhang AP et al: Association between a polymorphism of the HTR3A gene and therapeutic response to risperidone treatment in drug-naive Chinese schizophrenia patients. Pharmacogenet Genomics 2008; 18: 721\u2013727.","journal-title":"Pharmacogenet Genomics"},{"key":"BFejhg2009238_CR11","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1038\/sj.npp.1301619","volume":"33","author":"XY Zhang","year":"2008","unstructured":"Zhang XY, Zhou DF, Wu GY et al: BDNF levels and genotype are associated with antipsychotic-induced weight gain in patients with chronic schizophrenia. Neuropsychopharmacology 2008; 33: 2200\u20132205.","journal-title":"Neuropsychopharmacology"},{"key":"BFejhg2009238_CR12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0006-8993(02)03215-8","volume":"954","author":"J Chlan-Fourney","year":"2002","unstructured":"Chlan-Fourney J, Ashe P, Nylen K, Juorio AV, Li XM : Differential regulation of hippocampal BDNF mRNA by typical and atypical antipsychotic administration. Brain Res 2002; 954: 11\u201320.","journal-title":"Brain Res"},{"key":"BFejhg2009238_CR13","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.schres.2005.11.021","volume":"82","author":"A Pillai","year":"2006","unstructured":"Pillai A, Terry Jr AV, Mahadik SP : Differential effects of long-term treatment with typical and atypical antipsychotics on NGF and BDNF levels in rat striatum and hippocampus. Schizophr Res 2006; 82: 95\u2013106.","journal-title":"Schizophr Res"},{"key":"BFejhg2009238_CR14","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.jpsychires.2006.08.007","volume":"41","author":"XY Zhang","year":"2007","unstructured":"Zhang XY, Tan YL, Zhou DF et al: Serum BDNF levels and weight gain in schizophrenic patients on long-term treatment with antipsychotics. J Psychiatr Res 2007; 41: 997\u20131004.","journal-title":"J Psychiatr Res"},{"key":"BFejhg2009238_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15622970802182733","volume":"10","author":"EN Rizos","year":"2008","unstructured":"Rizos EN, Papadopoulou A, Laskos E et al: Reduced serum BDNF levels in patients with chronic schizophrenic disorder in relapse, who were treated with typical or atypical antipsychotics. World J Biol Psychiatry 2008; 10: 1\u20135.","journal-title":"World J Biol Psychiatry"},{"key":"BFejhg2009238_CR16","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1159\/000205518","volume":"59","author":"BH Lee","year":"2009","unstructured":"Lee BH, Kim YK : Increased plasma brain-derived neurotropic factor, not nerve growth factor-Beta, in schizophrenia patients with better response to risperidone treatment. Neuropsychobiology 2009; 59: 51\u201358.","journal-title":"Neuropsychobiology"},{"key":"BFejhg2009238_CR17","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0092-8674(03)00035-7","volume":"112","author":"MF Egan","year":"2003","unstructured":"Egan MF, Kojima M, Callicott JH et al: The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003; 112: 257\u2013269.","journal-title":"Cell"},{"key":"BFejhg2009238_CR18","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1097\/FPC.0b013e3282f85e26","volume":"18","author":"MQ Xu","year":"2008","unstructured":"Xu MQ, St Clair D, Feng GY et al: BDNF gene is a genetic risk factor for schizophrenia and is related to the chlorpromazine-induced extrapyramidal syndrome in the Chinese population. Pharmacogenet Genomics 2008; 18: 449\u2013457.","journal-title":"Pharmacogenet Genomics"},{"key":"BFejhg2009238_CR19","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/sj.mp.4000749","volume":"5","author":"MO Krebs","year":"2000","unstructured":"Krebs MO, Guillin O, Bourdell MC et al: Brain derived neurotrophic factor (BDNF) gene variants association with age at onset and therapeutic response in schizophrenia. Mol Psychiatry 2000; 5: 558\u2013562.","journal-title":"Mol Psychiatry"},{"key":"BFejhg2009238_CR20","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/S0304-3940(03)00828-0","volume":"349","author":"CJ Hong","year":"2003","unstructured":"Hong CJ, Yu YW, Lin CH, Tsai SJ : An association study of a brain-derived neurotrophic factor Val66Met polymorphism and clozapine response of schizophrenic patients. Neurosci Lett 2003; 349: 206\u2013208.","journal-title":"Neurosci Lett"},{"key":"BFejhg2009238_CR21","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1385\/NMM:5:3:243","volume":"5","author":"YJ Liou","year":"2004","unstructured":"Liou YJ, Liao DL, Chen JY et al: Association analysis of the dopamine D3 receptor gene ser9gly and brain-derived neurotrophic factor gene val66met polymorphisms with antipsychotic-induced persistent tardive dyskinesia and clinical expression in Chinese schizophrenic patients. Neuromolecular Med 2004; 5: 243\u2013251.","journal-title":"Neuromolecular Med"},{"key":"BFejhg2009238_CR22","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s00702-004-0233-9","volume":"112","author":"S Anttila","year":"2005","unstructured":"Anttila S, Illi A, Kampman O, Mattila KM, Lehtim\u00e4ki T, Leinonen E : Lack of association between two polymorphisms of brain-derived neurotrophic factor and response to typical neuroleptics. J Neural Transm 2005; 112: 885\u2013890.","journal-title":"J Neural Transm"},{"key":"BFejhg2009238_CR23","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.schres.2006.12.008","volume":"91","author":"MQ Xu","year":"2007","unstructured":"Xu MQ, St Clair D, Ott J, Feng GY, He L : Brain-derived neurotrophic factor gene C-270T and Val66Met functional polymorphisms and risk of schizophrenia: a moderate-scale population-based study and meta-analysis. Schizophr Res 2007; 91: 6\u201313.","journal-title":"Schizophr Res"},{"key":"BFejhg2009238_CR24","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1002\/ajmg.b.30619","volume":"147","author":"HM Chao","year":"2008","unstructured":"Chao HM, Kao HT, Porton B : BDNF Val66Met variant and age of onset in schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2008; 147: 505\u2013506.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"BFejhg2009238_CR25","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1038\/sj.npp.1301619","volume":"33","author":"XY Zhang","year":"2008","unstructured":"Zhang XY, Zhou DF, Wu GY et al: BDNF levels and genotype are associated with antipsychotic-induced weight gain in patients with chronic schizophrenia. Neuropsychopharmacology 2008; 33: 2200\u20132205.","journal-title":"Neuropsychopharmacology"},{"key":"BFejhg2009238_CR26","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1176\/appi.ajp.2007.05111903","volume":"164","author":"BC Ho","year":"2007","unstructured":"Ho BC, Andreasen NC, Dawson JD, Wassink TH : Association between brain-derived neurotrophic factor Val66Met gene polymorphism and progressive brain volume changes in schizophrenia. Am J Psychiatry 2007; 164: 1890\u20131899.","journal-title":"Am J Psychiatry"},{"key":"BFejhg2009238_CR27","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/j.pnpbp.2008.05.016","volume":"32","author":"SG Kang","year":"2008","unstructured":"Kang SG, Choi JE, An H et al: No association between the brain-derived neurotrophic factor gene Val66Met polymorphism and tardive dyskinesia in schizophrenic patients. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32: 1545\u20131548.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"BFejhg2009238_CR28","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.2217\/14622416.9.11.1589","volume":"9","author":"JK Rybakowski","year":"2008","unstructured":"Rybakowski JK : BDNF gene: functional Val66Met polymorphism in mood disorders and schizophrenia. Pharmacogenomics 2008; 9: 1589\u20131593.","journal-title":"Pharmacogenomics"},{"key":"BFejhg2009238_CR29","doi-asserted-by":"publisher","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","volume":"10","author":"JE Overall","year":"1962","unstructured":"Overall JE, Gorham DR : The brief psychiatric rating scale. Psychol Rep 1962; 10: 799\u2013812.","journal-title":"Psychol Rep"},{"key":"BFejhg2009238_CR30","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S0165-1781(99)00114-6","volume":"89","author":"D Lachar","year":"1999","unstructured":"Lachar D, Bailley SE, Rhoades HM, Varner RV : Use of BPRS-A percent change scores to identify significant clinical improvement: accuracy of treatment response classification in acute psychiatric inpatients. Psychiatry Res 1999; 89: 259\u2013268.","journal-title":"Psychiatry Res"},{"key":"BFejhg2009238_CR31","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.biopsych.2007.04.043","volume":"63","author":"S Kumra","year":"2008","unstructured":"Kumra S, Kranzler H, Gerbino-Rosen G et al: Clozapine and \u2018high-dose\u2019 olanzapine in refractory early-onset schizophrenia: a 12-week randomized and double-blind comparison. Biol Psychiatry 2008; 63: 524\u2013529.","journal-title":"Biol Psychiatry"},{"key":"BFejhg2009238_CR32","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0924-977X(03)00006-3","volume":"13","author":"G Zalsman","year":"2003","unstructured":"Zalsman G, Frisch A, Lev-Ran S et al: DRD4 exon III polymorphism and response to risperidone in Israeli adolescents with schizophrenia: a pilot pharmacogenetic study. Eur Neuropsychopharmacol 2003; 13: 183\u2013185.","journal-title":"Eur Neuropsychopharmacol"},{"key":"BFejhg2009238_CR33","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/j.1440-1819.2007.01633.x","volume":"61","author":"N Sakumoto","year":"2007","unstructured":"Sakumoto N, Kondo T, Mihara K, Suzuki A, Yasui-Furukori N : Dopamine D2 receptor gene polymorphisms predict well the response to dopamine antagonists at therapeutic dosages in patients with schizophrenia. Psychiatry Clin Neurosci 2007; 61: 174\u2013180.","journal-title":"Psychiatry Clin Neurosci"},{"key":"BFejhg2009238_CR34","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S1570-0232(02)00661-X","volume":"783","author":"A LLerena","year":"2003","unstructured":"LLerena A, Berecz R, Dorado P et al: Determination of risperidone and 9-hydroxyrisperidone in human plasma by liquid chromatography: application to the evaluation of CYP2D6 drug interactions. J Chromatogr B Analyt Technol Biomed Life Sci 2003; 783: 213\u2013219.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"BFejhg2009238_CR35","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1093\/bioinformatics\/bth457","volume":"21","author":"JC Barrett","year":"2005","unstructured":"Barrett JC, Fry B, Maller J, Daly MJ : Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263\u2013265.","journal-title":"Bioinformatics"},{"key":"BFejhg2009238_CR36","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1086\/319501","volume":"68","author":"M Stephens","year":"2001","unstructured":"Stephens M, Smith NJ, Donnelly P : A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68: 978\u2013989.","journal-title":"Am J Hum Genet"},{"key":"BFejhg2009238_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3758\/BF03203630","volume":"28","author":"E Erdfelder","year":"1996","unstructured":"Erdfelder E, Faul F, Buchner A : *Power: a general power analysis program. Behav Res Methods Instrum Comput 1996; 28: 1\u201311.","journal-title":"Behav Res Methods Instrum Comput"},{"key":"BFejhg2009238_CR38","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1086\/424390","volume":"75","author":"T Becker","year":"2004","unstructured":"Becker T, Knapp M : A powerful strategy to account for multiple testing in the context of haplotype analysis. Am J Hum Genet 2004; 75: 561\u2013570.","journal-title":"Am J Hum Genet"},{"key":"BFejhg2009238_CR39","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/clpt.2009.2","volume":"85","author":"A Gomez","year":"2009","unstructured":"Gomez A, Ingelman-Sundberg M : Pharmacoepigenetics: its role in interindividual differences in drug response. Clin Pharmacol Ther 2009; 85: 426\u2013430.","journal-title":"Clin Pharmacol Ther"},{"key":"BFejhg2009238_CR40","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/35075076","volume":"411","author":"O Guillin","year":"2001","unstructured":"Guillin O, Diaz J, Carroll P, Griffon N, Schwartz JC, Sokoloff P : BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization. Nature 2001; 411: 86\u201389.","journal-title":"Nature"},{"key":"BFejhg2009238_CR41","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/sj.npp.1301571","volume":"33","author":"K Martinowich","year":"2008","unstructured":"Martinowich K, Lu B : Interaction between BDNF and serotonin: role in mood disorders. Neuropsychopharmacology 2008; 33: 73\u201383.","journal-title":"Neuropsychopharmacology"},{"key":"BFejhg2009238_CR42","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1097\/01.wnr.0000175245.58708.6b","volume":"16","author":"D Gourion","year":"2005","unstructured":"Gourion D, Goldberger C, Leroy S, Bourdel MC, Oli\u00e9 JP, Krebs MO : Age at onset of schizophrenia: interaction between brain-derived neurotrophic factor and dopamine D3 receptor gene variants. Neuroreport 2005; 16: 1407\u20131410.","journal-title":"Neuroreport"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ejhg2009238.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ejhg2009238","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ejhg2009238.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T16:58:44Z","timestamp":1684429124000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ejhg2009238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1,20]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["BFejhg2009238"],"URL":"https:\/\/doi.org\/10.1038\/ejhg.2009.238","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1,20]]}}}